Richard Booth - Definitive Healthcare Chief Officer
| DH Stock | USD 4.66 0.02 0.43% |
Insider
Richard Booth is Chief Officer of Definitive Healthcare Corp
| Age | 55 |
| Address | 492 Old Connecticut Path, Framingham, MA, United States, 01701 |
| Phone | 508 720 4224 |
| Web | https://www.definitivehc.com |
Richard Booth Latest Insider Activity
Tracking and analyzing the buying and selling activities of Richard Booth against Definitive Healthcare stock is an integral part of due diligence when investing in Definitive Healthcare. Richard Booth insider activity provides valuable insight into whether Definitive Healthcare is net buyers or sellers over its current business cycle. Note, Definitive Healthcare insiders must abide by specific rules, including filing SEC forms every time they buy or sell Definitive Healthcare'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Richard Booth over three weeks ago Acquisition by Richard Booth of 92379 shares of Definitive Healthcare subject to Rule 16b-3 | ||
Richard Booth over three months ago Disposition of 993 shares by Richard Booth of Definitive Healthcare at 5.62 subject to Rule 16b-3 |
Definitive Healthcare Management Efficiency
The current Return On Tangible Assets is estimated to decrease to -0.5. The Definitive Healthcare's current Return On Capital Employed is estimated to increase to -0.19. As of now, Definitive Healthcare's Fixed Asset Turnover is decreasing as compared to previous years. Definitive Healthcare's management efficiency ratios could be used to measure how well Definitive Healthcare manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Andrew Douglas | Forian Inc | N/A | |
| Jessica Somers | Evolent Health | N/A | |
| Mark Smith | Phreesia | 68 | |
| Jason Jones | Health Catalyst | N/A | |
| Tyson Murdock | HealthEquity | 53 | |
| Allison Hoffman | Phreesia | 53 | |
| Scott Perricelli | Phreesia | 47 | |
| Craig Barbarosh | Evolent Health | 52 | |
| David Terrell | Forian Inc | N/A | |
| Jaap Mandema | Certara | N/A | |
| Peter Grua | Evolent Health | 66 | |
| Gillian Munson | Phreesia | 50 | |
| Paul Horstmeier | Health Catalyst | 63 | |
| Daniel Burton | Health Catalyst | 49 | |
| Adam Dublin | Forian Inc | 58 | |
| Charles Kallenbach | Phreesia | 55 | |
| Mark Grove | Forian Inc | N/A | |
| William Feehery | Certara | 53 | |
| Amy VanDuyn | Phreesia | 50 | |
| Ramin Sayar | Phreesia | 47 | |
| Dusty Lieb | Phreesia | N/A | |
Management Performance
| Return On Equity | -0.55 | ||||
| Return On Asset | -0.0076 |
Definitive Healthcare Leadership Team
Elected by the shareholders, the Definitive Healthcare's board of directors comprises two types of representatives: Definitive Healthcare inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Definitive. The board's role is to monitor Definitive Healthcare's management team and ensure that shareholders' interests are well served. Definitive Healthcare's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Definitive Healthcare's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Jon Maack, President | ||
| Tom Penque, Chief Officer | ||
| Matt Ruderman, Chief Secretary | ||
| David Kronfeld, Chief Officer | ||
| Jonathan Maack, President | ||
| Richard CPA, Chief Officer | ||
| Justin Steinman, Chief Officer | ||
| Craig Hazenfield, Chief Officer | ||
| Scott Oberlink, Chief Officer | ||
| Ram Sharma, Executive Sciences | ||
| Kevin Coop, CEO Director | ||
| Jason Krantz, Executive Founder | ||
| Kate Jensen, Chief Officer | ||
| William Moschella, Chief Officer | ||
| Robert JD, CEO Director | ||
| Richard Booth, Chief Officer | ||
| Carrie Lazorchak, Chief Officer | ||
| Matthew Ruderman, Chief Secretary | ||
| Joseph Mirisola, Chief Officer |
Definitive Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Definitive Healthcare a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.55 | ||||
| Return On Asset | -0.0076 | ||||
| Profit Margin | (1.42) % | ||||
| Operating Margin | 0.01 % | ||||
| Current Valuation | 490.14 M | ||||
| Shares Outstanding | 115.52 M | ||||
| Shares Owned By Insiders | 3.91 % | ||||
| Shares Owned By Institutions | 94.76 % | ||||
| Number Of Shares Shorted | 2.71 M | ||||
| Price To Book | 1.06 X |
Currently Active Assets on Macroaxis
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Definitive Healthcare Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Is Health Care Technology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Definitive Healthcare. If investors know Definitive will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Definitive Healthcare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.09) | Revenue Per Share 2.187 | Quarterly Revenue Growth (0.04) | Return On Assets (0.01) | Return On Equity (0.55) |
The market value of Definitive Healthcare is measured differently than its book value, which is the value of Definitive that is recorded on the company's balance sheet. Investors also form their own opinion of Definitive Healthcare's value that differs from its market value or its book value, called intrinsic value, which is Definitive Healthcare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Definitive Healthcare's market value can be influenced by many factors that don't directly affect Definitive Healthcare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Definitive Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine if Definitive Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Definitive Healthcare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.